Sectoral Asset Management

Sectoral Asset Management

Sectoral Asset Management

Suggest edits
Follow us
Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing
Built with ❤︎ by Datalicious ©2021
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 14

Portfolio

Portfolio Tracker

Add info
Add round
21 Jul 2020
CurvaFix
CurvaFix
$10,750,000
Venture capital (Series B)
Sectoral Asset Management, Delta Dental Washington Seed Fund

CurvaFix Closes $10.75M Series B Financing

FinSMEs
10 Jun 2020
Checkmate Pharmaceuticals
Checkmate Pharmaceuticals
$85,000,000
Venture capital (Series C)
Omega Funds, Longitude Capital, Sectoral Asset Management, +8

Checkmate Pharmaceuticals Raises $85M in Series C Financing

FinSMEs
+1
03 Jun 2020
Prilenia
Prilenia
$62,500,000
Venture capital (Series A)
Forbion Capital Partners, Sectoral Asset Management, Morningside Venture Investments, +1

Prilenia Therapeutics Raises $62.5M in Series A Funding

FinSMEs
30 Nov 2018
Aprea
Aprea
€50,000,000
Venture capital (Series C)
Redmile Group, Versant Ventures, HealthCap, +4

Aprea Therapeutics Closes €50M Series C Financing

FinSMEs
+1
09 May 2018
BioClin Therapeutics
BioClin Therapeutics
$20,000,000
Venture capital (Series B)
INKEF Capital, HealthCap, Sofinnova Ventures, +4

BioClin Therapeutics Raises $20M; Completes $50M Series B Financing

FinSMEs
09 Feb 2018
Simplify Medical, Inc.
Simplify Medical, Inc.
$23,000,000
Venture capital (Series B)
Life Sciences Partners, Sectoral Asset Management, M. H. Carnegie & Co., +4

Simplify Medical Closes $23.25M in Second Tranche of Series B Financing Totaling $44.25M

FinSMEs
10 Aug 2017
Apellis Pharma
Apellis Pharma
$60,000,000
Venture capital (Series E)
Epidarex Capital, Sofinnova Ventures, Cormorant Asset Management, +6

https://www.bizjournals.com/louisville/news/2017/08/10/local-company-gets-60-million-in-financing.html?ana=twt

bizjournals
+1
24 Jul 2017
Effector Therapeutics
Effector Therapeutics
$38,600,000
Venture capital (Series C)
SR One, Novartis Venture Fund, U.S. Venture Partners (USVP), +9

Effector Raises $38.6M to Advance New Class of Anti-Cancer Drugs

Xconomy
+1
19 Jul 2017
Simplify Medical, Inc.
Simplify Medical, Inc.
$21,000,000
Venture capital (Series B)
Life Sciences Partners, Sectoral Asset Management, M. H. Carnegie & Co, +1

Simplify Medical Closes $21 Million Series B Financing to Support Innovative Cervical Artificial Disc

businesswire
22 Nov 2016
Shockwave Medical, Inc.
Shockwave Medical, Inc.
$45,000,000
Venture capital (Series C)
RA Capital Management, Venrock, Sofinnova Partners, +4

Shockwave Medical raises $45m Series C for Lithoplasty device

MassDevice
+1
20 Jun 2016
F2G
F2G
$60,000,000
Venture capital
Sunstone Capital, Aisling Capital, Novartis Venture Fund, +5

UK Biotech Company F2G Raises $60M

FinSMEs
09 Mar 2016
Aprea
Aprea
€46,000,000
Venture capital (Series B)
Versant Ventures, HealthCap, 5AM Ventures, +1

Aprea AB: Cancer Company Aprea Closes EUR 46 Million (~USD 51 Million) Series B Financing

businesswire
+2
11 Jun 2015
Unum Therapeutics
Unum Therapeutics
$65,000,000
Venture capital (Series B)
Atlas Venture, Wellington Management, New Leaf Venture Partners, +9
29 Apr 2013
RainDance
RainDance
$20,000,000
Venture capital (Series E)
Mohr Davidow Ventures, Alloy Ventures, Acadia Woods Partners, +2